1. Home
  2. Labeler Index
  3. Macleods Pharmaceuticals Limited
  4. 33342-094
  5. NDC Package Code: 33342-094-23 Rizatriptan Benzoate

NDC Package 33342-094-23 Rizatriptan Benzoate

Tablet, Orally Disintegrating Oral - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
33342-094-23
Package Description:
18 TABLET, ORALLY DISINTEGRATING in 1 CONTAINER
Product Code:
33342-094
Proprietary Name:
Rizatriptan Benzoate
Non-Proprietary Name:
Rizatriptan Benzoate
Substance Name:
Rizatriptan Benzoate
Usage Information:
Rizatriptan is used to treat migraines. It helps to relieve headache, pain, and other migraine symptoms (including nausea, vomiting, sensitivity to light/sound). Prompt treatment helps you return to your normal routine and may decrease your need for other pain medications. Rizatriptan belongs to a class of drugs known as triptans. It affects a certain natural substance (serotonin) that causes narrowing of blood vessels in the brain. It may also relieve pain by affecting certain nerves in the brain. Rizatriptan does not prevent future migraines or lessen how often you get migraine attacks.
11-Digit NDC Billing Format:
33342009423
NDC to RxNorm Crosswalk:
  • RxCUI: 312837 - rizatriptan benzoate 10 MG Disintegrating Oral Tablet
  • RxCUI: 312837 - rizatriptan 10 MG Disintegrating Oral Tablet
  • RxCUI: 312837 - rizatriptan 10 MG (as rizatriptan benzoate 14.53 MG) Disintegrating Oral Tablet
  • RxCUI: 312839 - rizatriptan benzoate 5 MG Disintegrating Oral Tablet
  • RxCUI: 312839 - rizatriptan 5 MG Disintegrating Oral Tablet
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Macleods Pharmaceuticals Limited
    Dosage Form:
    Tablet, Orally Disintegrating - A solid dosage form containing medicinal substances which disintegrates rapidly, usually within a matter of seconds, when placed upon the tongue.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
    • Active Ingredient(s):
  • RIZATRIPTAN BENZOATE 10 mg/1
    • Pharmacologic Class(es):
  • Serotonin 1b Receptor Agonists - [MoA] (Mechanism of Action)
  • Serotonin 1d Receptor Agonists - [MoA] (Mechanism of Action)
  • Serotonin-1b and Serotonin-1d Receptor Agonist - [EPC] (Established Pharmacologic Class)
    • Sample Package:
    No
    FDA Application Number:
    ANDA203146
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    09-23-2014
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    33342-094-0412 TABLET, ORALLY DISINTEGRATING in 1 CONTAINER
    33342-094-0730 TABLET, ORALLY DISINTEGRATING in 1 CONTAINER
    33342-094-1210 BLISTER PACK in 1 CARTON / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK
    33342-094-413 BLISTER PACK in 1 CARTON / 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK
    33342-094-452 BLISTER PACK in 1 CARTON / 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK
    33342-094-46200 TABLET, ORALLY DISINTEGRATING in 1 CONTAINER
    33342-094-474 POUCH in 1 CARTON / 1 BLISTER PACK in 1 POUCH / 5 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK
    33342-094-521 BLISTER PACK in 1 CARTON / 3 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK
    33342-094-726 BLISTER PACK in 1 CARTON / 3 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK
    33342-094-733 BLISTER PACK in 1 CARTON / 3 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 33342-094-23?

    The NDC Packaged Code 33342-094-23 is assigned to a package of 18 tablet, orally disintegrating in 1 container of Rizatriptan Benzoate, a human prescription drug labeled by Macleods Pharmaceuticals Limited. The product's dosage form is tablet, orally disintegrating and is administered via oral form.

    Is NDC 33342-094 included in the NDC Directory?

    Yes, Rizatriptan Benzoate with product code 33342-094 is active and included in the NDC Directory. The product was first marketed by Macleods Pharmaceuticals Limited on September 23, 2014 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 33342-094-23?

    The 11-digit format is 33342009423. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-233342-094-235-4-233342-0094-23